Skip to content

Pitch notes

Natalie Linton edited this page Dec 15, 2019 · 21 revisions

Slide 1

Slide 2

Slide 3

Slide 4

  • For every isolate submitted, ETD will generate an automated report highlighting emerging AMR genes and resistance mutations for that bacteria.
  • The report will present factors such as the resistance mechanism, drug class, and gene location affected.
  • In addition, it will provide qualitative assessments of outbreak risk and import probability.
  • This information can help public health consider whether this isolate or related samples require additional investigation.

Slide 5

  • This simple first page is supplemented by a detailed presentation and analyses of spatiotemporal, evolutionary, and gene mobility factors, as well as resistance patterns.
  • These reports can be stored locally and shared between public health professionals who may leverage the results presented in their work.
  • Newly detected emerging resistances will also be disseminated in a publicly accessible manner. Thus, they can be fed into curated news services to reach specialists, journalists, and the wider public.

Slide 6

  • The potential impact of ETD is wide-reaching.
  • It will greatly improve surveillance efforts, and consequently help guide antimicrobial stewardship and clinical decision-making.
  • Public health professionals and the clinicians and veterinarians will have a more complete picture of emerging AMR in the areas where they live and work.
Clone this wiki locally